ConvaTec Group PLC (LSE:CTEC) - Share price


Stock Report

ConvaTec Group PLC CTEC

Last Price
GBX247.70

Day Change
-1.60|-0.64%

As of 11/06/2021
18:28:27 BST | GBX
Minimum 15 Minutes Delay.

Last Close249.30p
Day Range246.20 - 250.20
Mkt Cap4.99Bil
52-Wk Range173.20 - 250.20
Yield %1.68
ISINGB00BD3VFW73
Volume1,738,810
P/E62.50
P/S2.62
P/CF12.45

Share Price

Total Returns 11/06/2021

 Chg (%)  
More ...
ConvaTec Group PLC11.08 
FTSE 100 TR GBP3.00
 
Financials
201820192020
More ...
Income Statement
Turnover1,832.101,827.201,894.30
Operating Profit267.70202.40211.00
Net Profit221.609.80112.50
Reported EPS0.110.010.06
Balance Sheet
Current Assets903.20968.301,178.50
Non Current Assets2,757.202,641.502,588.00
Total Assets3,660.403,609.803,766.50
Current Liabilities330.90397.30513.20
Total Liabilities---
Total Equity1,617.201,561.001,670.70
Cash Flow
Operating Cash Flow387.80438.80454.00
Net Change in Cash41.7076.50181.10

Regulatory News

DateAuthor Headline
08/06/2021James Gard Top FTSE Dividend Paying Stocks
UPDATED June 2021: Unilever is back in the number one slot
20/11/2018David Brenchley Which Stocks Did Managers Buy in October's Sell-Off?
As global stock markets continue to sell off, we asked fund managers which stocks they have either added to their portfolio or topped up their exposure to
12/11/2018David Brenchley Woodford and Barnett Hit as Tobacco Stocks Slump
British American Tobacco and Imperial Brands' share prices fell on Monday morning after weekend reports the US Food and Drug Administration is considering banning menthol cigarettes
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
13/05/2021DMr. Rick D. Anderson197.001,1362,238.00
13/05/2021DMr. Frank Schulkes222.8452116.00
15/10/2020DMr. Rick D. Anderson186.285471,019.00
15/10/2020DKarim Bitar177.507,33813,025.00

Company Profile

Originally spun out of Bristol-Myers Squibb, ConvaTec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy are the largest divisions, accounting for 33% and 30% of total revenue, respectively. Continence care contributes 21% of revenue and infusion sets 15%.

Sector

Medical Instruments & Supplies

Index

FTSE 250 , FTSE 350 , FTSE All Share

Next Event 06/08/2021

Half-Yearly Results
Ratios
Comp
More ...
PER (E)60.16
Div Yld (E)1.75
PEG (E)3.38
ROCE6.73
Op Mrgn0.11
EPS Grwth0.05
Dividends
PreviousLatest
More ...
Record Date04/09/2006/04/21
Ex-Div03/09/2001/04/21
Paid15/10/2013/05/21
Amnt1.312.85
Directors
More ...
Non-Executive DirectorMs. Heather L. Mason
Non-Executive DirectorMr. Rick D. Anderson
Non-Executive DirectorProfessor Sten Scheibye, PhD
Non-Executive Director, ChairmanDr. John David Gibson McAdam CBE
Non-Executive DirectorMr. Brian Michael May
Non-Executive Director, Senior Independent DirectorMs. Margaret Ewing
Executive Director, Chief Executive OfficerMr. Karim Bitar
Non-Executive DirectorDr. Regina M. Benjamin
Executive Director, Chief Financial OfficerMr. Frank Schulkes
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.